Gabapentin Capsule
Product Images NDC 80425-0079

8 FDA label images from Advanced Rx Of Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 80425-0079). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Gabapentin showing a cyclohexane ring with attached amino (CH2NH2) and carboxymethyl (CH2CO2H) groups.*
FDA Label Image

Fig 1 (Figure 1)

Fig 1 (Figure 1)
Line graph depicting mean pain score over 8 weeks during a study with a 4-week dose titration period followed by a 4-week fixed dose period. The graph compares placebo and Gabapentin at 3,600 mg/day dosages, showing pain score trends from baseline through weeks 1 to 8.*
FDA Label Image

Fig 2 (Figure 2)

Fig 2 (Figure 2)
A line graph depicting mean pain scores over a 7-week period including a 3-week dose titration and a 4-week fixed dose period. It compares placebo and two dosages of Gabapentin (1,800 mg/day and 2,400 mg/day) with values marked at baseline and weekly intervals.*
FDA Label Image

Fig 3 (Figure 3)

Fig 3 (Figure 3)
A bar chart comparing percentages between placebo (PBO) and Gabapentin (GBP) at various doses in two studies. Study 1 shows 12% for PBO and 29% for GBP 3,600 mg. Study 2 displays 14% for PBO, 32% for GBP 1,800 mg, and 34% for GBP 2,400 mg. Statistical significance is noted with p-values less than 0.01 and 0.001.*
FDA Label Image

Fig 4 (Figure 4)

Fig 4 (Figure 4)
A bar graph depicting percentage differences related to daily doses of gabapentin in milligrams (600, 900, 1200, 1800 mg) across three studies labeled a, b, and c. The graph uses different colored squares to represent each study and plots the percentage difference on the vertical axis.*
FDA Label Image

Label 1 (Lable 1)

Label 1 (Lable 1)
Packaging label for Gabapentin 300 mg capsules by Advanced Rx of Tennessee, LLC. The label displays dosage strength, route of administration (oral), package count (#30), storage conditions (20-25°C), and includes lot and expiration date information. It compares to Neurontin and shows related NDC codes and source NDC.*
FDA Label Image

Label 2 (Lable 2)

Label 2 (Lable 2)
Gabapentin 300 mg capsule packaging label by Advanced Rx of Tennessee, LLC. The label includes storage instructions (20°-25°C), a barcode, comparison to Neurontin with NDC 80425-0079-02, lot number G30040122, and expiration date 4/1/2022. Labeler information indicates Nashville, TN.*
FDA Label Image

Label 3 (Label 3)

Label 3 (Label 3)
Gabapentin 300 mg capsule label showing the product name, strength, dosage form, and labeler Advanced Rx of Tennessee, LLC. The label includes storage instructions (store at 20°-25°C), a comparison to Neurontin with NDC numbers, lot number G30040122, and an expiration date of 4/1/2022. The label also features a QR code and additional manufacturing details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.